US health panel recommends easing restrictions on controversial peptides. Photograph: Bloomberg/Getty ImagesTrump administrationUS health panel recommends easing restrictions on controversial peptidesVote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK Jr.
A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals have not been shown to be safe or effective.
Details
The panel’s vote is not binding but is likely to embolden the health secretary, Robert F Kennedy Jr, who has described himself as a “big fan” of peptides and vowed to overturn FDA restrictions put in place under Joe Biden.
Photograph: Bloomberg/Getty Images View image in fullscreen The panel voted 8-6 in favor of putting the peptides on FDA’s list of substances considered safe for pharmacy compounding.
In a series of votes, outside experts to the Food and Drug Administration advised the agency to drop current restrictions barring pharmacies from producing injectable peptides with names like BPC-157, TB-500 and KPV.
The panel voted 8-6 in favor of putting the peptides on FDA’s list of substances considered safe for pharmacy compounding.
Across several votes, the panelists voted 8-6, with one abstention, in favor of putting the peptides on FDA’s list of substances considered safe for pharmacy compounding.
Available information indicates that The panel will on Friday vote on three more peptides.
16:00 The peptide boom: how the US got hooked on unregulated ‘miracle’ drugs | On the GroundPanel members with backgrounds in academia, rather than peptides, mostly voted against the substances, which are widely advertised on social media.
Peptide supporters include the podcaster Joe Rogan and longevity influencers such as Gary Brecka, a supporter of Kennedy’s “Make America Healthy Again” agenda who sells peptides through his website.
Statements
Context
Health Secretary Robert F Kennedy Jr., who ultimately oversees the FDA, has publicly endorsed easing restrictions on peptides.
defends his health agenda and Trump's proposed budget cuts in hearing An analysis presented by FDA scientists didn't support easing restrictions on BPC-157, often used for ulcerative colitis, or KPV, a peptide used for inflammation.
A panel of advisers to the Food and Drug Administration is recommending that the federal government green-light the production of two popular peptides by specialized pharmacies in the U.S.
The actions came during a highly anticipated two-day meeting that began Thursday to consider whether current Biden-era restrictions on production of seven different peptides — none of which are approved drugs — should be lifted.
Separately, Advisers to the Food and Drug Administration voted in favor of easing regulation of popular peptides.
A panel of advisers to the Food and Drug Administration is making recommendations on seven popular peptides.
